<p>Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation</p>

David Mannino; Michael Bogart; Guillaume Germain; Shirley P Huang; Afisi S Ismaila; François Laliberté; Young Jung; Sean D MacKnight; Marjorie A Stiegler; Mei Sheng Duh

doi:10.2147/COPD.S337668

open access to scientific and medical research

Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 17

Original Research

Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation

Total article views		HTML views	PDF downloads	Totals
7,894	Dovepress*	6,855+	407	7,262
	PubMed Central*	1,039	538	1,577
	Totals	7,894	945	8,839
*Since 5 March 2022

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.